Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-07-01 Sale | 2025-07-03 4:30 pm | BridgeBio Pharma Inc. | BBIO | Kumar Neil Chief Executive Officer | 80,000 | $42.63 | $3,410,450 | 1,173,090 (Indirect Direct) | View |
| 2025-06-27 Sale | 2025-07-01 7:48 pm | BridgeBio Pharma Inc. | BBIO | VIKING GLOBAL INVESTORS LP Viking Global Opportunities Parent GP LLC Viking Global Opportunities GP LLC Viking Global Opportunities Portfolio GP LLC Viking Global Opportunities Illiquid Investments Sub-Master LP HALVORSEN OLE ANDREAS Ott David C. Shabet Rose Sharon 10% Owner | 3,500,000 | $44 | $154,000,000 | 18,555,375 (Indirect) | View |
| 2025-06-26 Sale | 2025-06-30 5:51 pm | BridgeBio Pharma Inc. | BBIO | Valantine Hannah Director | 4,707 | $44.05 | $207,327 | 7,863 (Indirect Direct) | View |
| 2021-12-29 Purchase(A) | 2025-06-30 5:49 pm | BridgeBio Pharma Inc. | BBIO | Valantine Hannah Director | 1,752 | $14.24 | $24,948 | 5,981 (Indirect Direct) | View |
| 2021-12-28 Purchase(A) | 2025-06-30 5:46 pm | BridgeBio Pharma Inc. | BBIO | Valantine Hannah Director | 2,338 | $12.84 | $30,028 | 4,229 (Indirect Direct) | View |
| 2025-06-24 Sale | 2025-06-26 5:08 pm | BridgeBio Pharma Inc. | BBIO | MCCORMICK FRANK Director | 100,000 | $44.23 | $4,422,800 | 963,254 (Indirect Direct) | View |
| 2025-06-10 Sale | 2025-06-11 5:00 pm | BridgeBio Pharma Inc. | BBIO | Valantine Hannah Director | 4,292 | $40 | $171,680 | 39,531 (Indirect Direct) | View |
| 2025-05-19 Sale | 2025-05-20 6:06 pm | BridgeBio Pharma Inc. | BBIO | Kumar Neil Chief Executive Officer | 101,156 | $33.38 | $3,376,741 | 6,635,244 (Indirect Direct) | View |
| 2025-05-12 Sale | 2025-05-14 5:24 pm | BridgeBio Pharma Inc. | BBIO | KKR Genetic Disorder L.P. KKR Genetic Disorder GP LLC KKR Group Partnership L.P. KKR Group Holdings Corp. KKR Group Co. Inc. KKR & Co. Inc. KKR Management LLP KRAVIS HENRY R ROBERTS GEORGE R 10% Owner | 6,000,000 | $34.2 | $205,200,000 | 13,260,971 (Indirect) | View |
| 2025-05-02 Sale | 2025-05-06 4:45 pm | BridgeBio Pharma Inc. | BBIO | Apuli Maricel Chief Accounting Officer | 1,026 | $38.51 | $39,509 | 147,639 (Direct) | View |
| 2025-05-02 Sale | 2025-05-06 4:42 pm | BridgeBio Pharma Inc. | BBIO | Lo Andrew Director | 100,000 | $38.5 | $3,849,900 | 153,682 (Indirect Direct) | View |
| 2025-04-22 Sale | 2025-04-24 4:28 pm | BridgeBio Pharma Inc. | BBIO | Kumar Neil Chief Executive Officer | 75,000 | $34.11 | $2,558,025 | 6,080,851 (Indirect Direct) | View |
| 2025-04-14 Sale | 2025-04-16 5:39 pm | BridgeBio Pharma Inc. | BBIO | Ellis Andrea Director | 10,000 | $35 | $350,000 | 76,921 (Direct) | View |
| 2025-04-01 Sale | 2025-04-03 5:11 pm | BridgeBio Pharma Inc. | BBIO | Ellis Andrea Director | 30,000 | $34.05 | $1,021,500 | 86,921 (Direct) | View |
| 2025-03-25 Sale | 2025-03-27 4:54 pm | BridgeBio Pharma Inc. | BBIO | Kumar Neil Chief Executive Officer | 75,000 | $36.87 | $2,764,943 | 6,155,851 (Indirect Direct) | View |
| 2025-03-06 Sale | 2025-03-10 4:43 pm | BridgeBio Pharma Inc. | BBIO | Valantine Hannah Director | 12,875 | $32.58 | $419,500 | 43,823 (Indirect Direct) | View |
| 2025-03-05 Sale | 2025-03-07 6:09 pm | BridgeBio Pharma Inc. | BBIO | KKR Genetic Disorder L.P. KKR Genetic Disorder GP LLC KKR Group Partnership L.P. KKR Group Holdings Corp. KKR Group Co. Inc. KKR & Co. Inc. KKR Management LLP KRAVIS HENRY R ROBERTS GEORGE R 10% Owner | 6,000,000 | $32.96 | $197,760,000 | 19,260,971 (Indirect) | View |
| 2025-02-25 Sale | 2025-02-27 5:36 pm | BridgeBio Pharma Inc. | BBIO | STEPHENSON BRIAN C CFO and Treasurer | 8,500 | $33.19 | $282,115 | 542,634 (Direct) | View |
| 2025-02-25 Sale | 2025-02-27 5:12 pm | BridgeBio Pharma Inc. | BBIO | Kumar Neil Chief Executive Officer | 75,000 | $33.57 | $2,517,971 | 6,230,851 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-06-27 Gift | 2025-06-30 5:54 pm | N/A N/A | BridgeBio Pharma Inc. | BBIO | HOMCY CHARLES J Director | 20,000 | $0 | 1,216,674 (Direct) | View |
| 2025-06-20 Option Award | 2025-06-24 7:13 pm | N/A 2035-06-19 | BridgeBio Pharma Inc. | BBIO | Lo Andrew Director | 15,014 | $0 | 168,696 (Direct) | View |
| 2025-06-20 Option Award | 2025-06-24 7:12 pm | N/A 2035-06-19 | BridgeBio Pharma Inc. | BBIO | Ellis Andrea Director | 15,014 | $0 | 27,014 (Direct) | View |
| 2025-06-20 Option Award | 2025-06-24 7:10 pm | N/A 2035-06-19 | BridgeBio Pharma Inc. | BBIO | Cook Jennifer E. Director | 15,014 | $0 | 22,166 (Direct) | View |
| 2025-06-20 Option Award | 2025-06-24 7:07 pm | N/A 2035-06-19 | BridgeBio Pharma Inc. | BBIO | MCCORMICK FRANK Director | 15,014 | $0 | 988,487 (Direct) | View |
| 2025-06-20 Option Award | 2025-06-24 7:07 pm | N/A 2035-06-19 | BridgeBio Pharma Inc. | BBIO | AGUIAR ERIC Director | 15,014 | $0 | 15,014 (Direct) | View |
| 2025-06-20 Option Award | 2025-06-24 7:06 pm | N/A 2035-06-19 | BridgeBio Pharma Inc. | BBIO | DANIELS RONALD J Director | 15,014 | $0 | 25,416 (Direct) | View |
| 2025-06-20 Option Award | 2025-06-24 7:06 pm | N/A 2035-06-19 | BridgeBio Pharma Inc. | BBIO | Satvat Ali J. Director | 15,014 | $0 | 174,418 (Direct) | View |
| 2025-06-20 Option Award | 2025-06-24 6:57 pm | N/A 2035-06-19 | BridgeBio Pharma Inc. | BBIO | MOMTAZEE JAMES C Director | 15,014 | $0 | 103,505 (Direct) | View |
| 2025-06-20 Option Award | 2025-06-24 6:56 pm | N/A 2035-06-19 | BridgeBio Pharma Inc. | BBIO | HOMCY CHARLES J Director | 15,014 | $0 | 1,245,099 (Direct) | View |
| 2025-06-20 Option Award | 2025-06-24 6:56 pm | N/A 2035-06-19 | BridgeBio Pharma Inc. | BBIO | Hassan Fred Director | 15,014 | $0 | 34,314 (Direct) | View |
| 2025-06-20 Option Award | 2025-06-24 6:55 pm | N/A 2035-06-19 | BridgeBio Pharma Inc. | BBIO | Dachille Douglas A. Director | 15,014 | $0 | 35,014 (Direct) | View |
| 2025-06-20 Option Award | 2025-06-24 6:55 pm | N/A 2035-06-19 | BridgeBio Pharma Inc. | BBIO | Valantine Hannah Director | 15,014 | $0 | 20,211 (Direct) | View |
| 2025-06-20 Option Award | 2025-06-24 6:54 pm | N/A 2035-06-19 | BridgeBio Pharma Inc. | BBIO | Scott Randal W. Director | 15,014 | $0 | 24,014 (Direct) | View |
| 2025-06-10 Exercise | 2025-06-11 5:00 pm | N/A 2033-06-21 | BridgeBio Pharma Inc. | BBIO | Valantine Hannah Director | 4,292 | $0 | 39,531 (Direct) | View |
| 2025-06-10 Exercise | 2025-06-11 5:00 pm | N/A N/A | BridgeBio Pharma Inc. | BBIO | Valantine Hannah Director | 4,292 | $16.75 | 39,531 (Direct) | View |
| 2025-05-16 Tax Withholding | 2025-05-20 6:06 pm | N/A N/A | BridgeBio Pharma Inc. | BBIO | Kumar Neil Chief Executive Officer | 32,854 | $33.84 | 6,635,244 (Direct) | View |
| 2025-05-16 Exercise | 2025-05-20 6:06 pm | N/A N/A | BridgeBio Pharma Inc. | BBIO | Kumar Neil Chief Executive Officer | 129,392 | $0 | 6,635,244 (Direct) | View |
| 2025-05-16 Tax Withholding | 2025-05-20 5:07 pm | N/A N/A | BridgeBio Pharma Inc. | BBIO | Trimarchi Thomas President and CFO | 21,317 | $33.84 | 501,988 (Direct) | View |
| 2025-05-16 Tax Withholding | 2025-05-20 5:05 pm | N/A N/A | BridgeBio Pharma Inc. | BBIO | Apuli Maricel Chief Accounting Officer | 4,780 | $33.84 | 142,859 (Direct) | View |
| 2025-05-07 Gift | 2025-05-09 6:00 pm | N/A N/A | BridgeBio Pharma Inc. | BBIO | MCCORMICK FRANK Director | 36,000 | $0 | 1,056,665 (Direct) | View |
| 2025-04-14 Exercise | 2025-04-16 5:39 pm | N/A N/A | BridgeBio Pharma Inc. | BBIO | Ellis Andrea Director | 10,000 | $8.45 | 76,921 (Direct) | View |
| 2025-04-14 Exercise | 2025-04-16 5:39 pm | N/A 2032-06-22 | BridgeBio Pharma Inc. | BBIO | Ellis Andrea Director | 10,000 | $0 | 76,921 (Direct) | View |
| 2025-04-01 Exercise | 2025-04-03 5:11 pm | N/A N/A | BridgeBio Pharma Inc. | BBIO | Ellis Andrea Director | 30,000 | $8.45 | 86,921 (Direct) | View |
| 2025-04-01 Exercise | 2025-04-03 5:11 pm | N/A 2032-06-22 | BridgeBio Pharma Inc. | BBIO | Ellis Andrea Director | 30,000 | $0 | 86,921 (Direct) | View |
| 2025-03-19 Option Award | 2025-03-21 6:32 pm | N/A N/A | BridgeBio Pharma Inc. | BBIO | Trimarchi Thomas President and CFO | 109,100 | $0 | 523,305 (Direct) | View |
| 2025-03-19 Option Award | 2025-03-21 6:09 pm | N/A 2035-03-18 | BridgeBio Pharma Inc. | BBIO | Kumar Neil Chief Executive Officer | 256,068 | $0 | 256,068 (Direct) | View |
| 2025-03-19 Option Award | 2025-03-21 6:03 pm | N/A N/A | BridgeBio Pharma Inc. | BBIO | Apuli Maricel Chief Accounting Officer | 23,660 | $0 | 148,665 (Direct) | View |
| 2025-03-06 Exercise | 2025-03-10 4:43 pm | N/A 2033-06-21 | BridgeBio Pharma Inc. | BBIO | Valantine Hannah Director | 12,875 | $0 | 43,823 (Direct) | View |
| 2025-03-06 Exercise | 2025-03-10 4:43 pm | N/A N/A | BridgeBio Pharma Inc. | BBIO | Valantine Hannah Director | 12,875 | $16.75 | 43,823 (Direct) | View |
Ownership | 2025-02-27 8:22 pm | N/A N/A | BridgeBio Pharma Inc. | BBIO | Apuli Maricel Chief Accounting Officer | 0 | $0 | 125,005 (Direct) | View |
| 2025-02-25 Exercise | 2025-02-27 5:36 pm | N/A N/A | BridgeBio Pharma Inc. | BBIO | STEPHENSON BRIAN C CFO and Treasurer | 8,500 | $17 | 542,634 (Direct) | View |
| 2025-02-25 Exercise | 2025-02-27 5:36 pm | N/A 2029-06-26 | BridgeBio Pharma Inc. | BBIO | STEPHENSON BRIAN C CFO and Treasurer | 8,500 | $0 | 542,634 (Direct) | View |